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ABSTRACT
According to the World Cancer Research Fund International (WCRFI), breast cancer is the most common type of cancer in 
women worldwide with recorded 1.7 million new cases in 2012. The main line of treatments is still limited to chemotherapy, 
surgery and radiotherapy which could lead to a wide range of dangerous side effects. This study was conducted to evaluate 
the effect of low intensity ultrasound (LIUS) on cell proliferation, percentage of living and dead cells and the induction of 
apoptosis on the MCF-7 cell line with CHO cells as the control for non-cancerous group. In order to achieve the objective 
of this study, several methods of cell-bioguided assays were used including the MTT assay for cell proliferation, Live/
Dead assay for the determination of both live and dead cells and gene expression study for the detection of apoptosis 
in the cells. The cytotoxicity and Live/Dead assays data provided preliminary data that the LIUS has potential to induce 
apoptosis in a wide population of breast cancer cells. Furthermore, the LIUS treatment induced the expression of p53-
mRNA at a detectable level via qPCR analysis, indicating the activation of apoptosis. In short, our study suggested LIUS 
dosage used in this study could potentially show positive effects in the induction of apoptosis selectively on the MCF-7 
with less harm to the control CHO cells. 
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ABSTRAK
Merujuk kepada ‘World Cancer Research Fund International’ (WCRFI), kanser payudara adalah jenis kanser yang 
paling umum pada wanita di seluruh dunia dengan catatan rekod 1.7 juta kes baru pada 2012. Rawatan utama masih 
lagi terhad kepada kimoterapi, pembedahan dan radioterapi yang boleh membawa kepada pelbagai kesan sampingan 
berbahaya. Penyelidikan ini dijalankan untuk menilai kesan ultrabunyi berkeamatan rendah (LIUS) pada pertumbuhan 
sel, peratusan hidup dan mati sel dan juga pengaruhan ‘apoptosis’ pada jujukan sel MCF-7 dan CHO sebagai kumpulan 
kawalan sel bukan kanser. Untuk mencapai objektif di dalam kajian ini, beberapa kaedah bioasai berdasarkan sel telah 
digunakan termasuklah asai MTT untuk pertumbuhan sel, asai ‘Live/Dead’ untuk pengenalpastian hidup dan mati sel 
dan juga kajian ekspresi gen untuk pengesanan ‘apoptosis’ pada sel. Asai sitotoksiti dan ‘Live/Dead’ menggambarkan 
data awal bahawa LIUS berpotensi untuk mengaruh ‘apoptosis’ di dalam populasi yang besar bagi kanser payudara. 
Tambahan lagi, rawatan LIUS juga berpotensi untuk mengaruh ekspresi p53-mRNA pada aras yang dapat dikesan melalui 
analisis qPCR yang menunjukkan pengaktifan ‘apoptosis. Kesimpulannya, kajian kami mencadangkan dos LIUS yang 
digunakan dalam kajian ini berpotensi dalam menunjukkan kesan positif dalam pengaruhan ‘apoptosis’ pilihan pada 
sel MCF-7 dengan sedikit kemudaratan kepada sel CHO.
Kata kunci: Apoptosis; LIUS; qPCR; sel CHO; sel MCF-7
INTRODUCTION
Breast cancer is the second most reported case of cancer 
in women, worldwide. In order to control and suppress 
growth of breast cancer, the treatment regimen available 
nowadays is limited to chemotherapy, radiotherapy, surgery 
(Guo 2014; Hortobagyi et al. 2005) and hormone therapy, 
where estrogen and progesterone receptors detected on 
cancer cells will be targeted for hormone receptor blockers. 
Recent studies suggested new effective approaches in the 
treatment of breast cancer by employing small molecule 
inhibitors in combination and/or in sequence with radio- 
and chemotherapy compounds, rendering high efficiency of 
the treatment and increasing the overall survival of patients 
(Garg & Buchholz 2015; Komen et al. 2008). In addition 
to these new approaches, employing alternative methods 
such as ultrasound (US), sonodynamic (SDT), photodynamic 
therapy (PDT) and hyperthermia treatment can increase the 
prospect of treating breast cancer through the induction 
of apoptosis (Li et al. 2012). Ultrasound is defined as a 
mechanical vibration produced via sound wave with the 
frequency of more than 20 kHz (Wood & Sehgal 2015). 
It is well-noted that the effective therapeutic frequency 
of ultrasound is in the range of 0.8 to 3 MHz (Cambier 
et al. 2001; Wu & Nyborg 2006). Physically, the result of 
this continuous sound wave could lead to cell damage via 
cavitation (Ninomiya et al. 2014) and by increasing the 
temperature of the cell microenvironment (Cambier et al. 
2001; Johns 2002; Larina et al. 2005; Shibaguchi et al. 2011). 
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Previously, the combination treatment using ultrasound with 
a 5-Fluorouracil drug increased the expression of apoptotic 
protein. However, addition of the Optison drug, resulted in 
suppression of the apoptotic protein expression (Chumakova 
et al. 2006). In addition, recent studies showed that the use of 
ultrasound technique together with chemotherapy drug such 
as Cisplatin could potentially induce apoptosis in cancer 
cells (Li et al. 2012). In this study, we used low intensity 
ultrasound to induce apoptosis independently without 
combination with any chemotherapy drug. 
MATERIALS AND METHODS
MATERIALS
Roswell Park Memorial Institute (RPMI) 1640 medium 
with 2% L-Glutamine were purchased from Biowest 
(Puchong, Selangor, Malaysia). Phosphate Buffer Saline 
(PBS) and Propidium Iodide for Live/Dead Assay were 
purchased from Sigma-Aldrich (Subang Jaya, Selangor, 
Malaysia). Trypsin was purchased from Gibco (Petaling 
Jaya, Selangor, Malaysia). The Trypan Blue solution was 
purchased from Bio-basic (Puchong, Selangor, Malaysia) 
and Calcein AM of Live/Dead assay was purchased from 
Life Technologies (Petaling Jaya, Selangor, Malaysia). 
3-(4,5-dimethylthiazol-2,5-diphenyl tetrazolium bromide 
(MTT) was purchased from Sigma-Aldrich Group (Petaling 
Jaya, Selangor, Malaysia). RNA Isolation Kit, Thermo 
Scientific Maxima Reverse Transcriptase and SYBR Green 
were purchased from Thermo Fisher Scientific (Shah Alam, 
Selangor, Malaysia). Trypsin/EDTA was purchased from 
Gibco (Petaling Jaya, Selangor, Malaysia). The penicillin/
streptomycin antibiotic for cell culture were purchased 
from Gibco (Petaling Jaya, Selangor, Malaysia). 
CELL CULTURE
The breast cancer cell lines, MCF-7 and non-cancerous 
cells, CHO (Chinese Hamster Ovary) used as a control, were 
purchase from American types of cancer cell, ATCC (USA) 
and was a generous gift from Dr Sallehuddin Hamdan 
from the Animal Tissue Culture Laboratory, Faculty 
of Biosciences and Medical Engineering, Universiti 
Teknologi Malaysia. The cells were cultured in RPMI-1640 
supplemented with 10% FBS and 1% Pen/Strep, incubated 
in CO2 incubator at 37oC.
OPTIMIZING SEEDING DENSITY
The cancer cells (MCF-7) were trypsinized and seeded 
into six-well plate containing RPMI 1640 with the seeding 
densities ranging from 5×105 to 1×106 cells/mL. The same 
procedure was performed for CHO (as the non-cancerous 
control cells) with seeding densities of 4×105 to 9×105 
cells/mL as the CHO cells proliferate faster than MCF-7 
cells. The cells were then incubated in the CO2 incubator 
until it reaches 70-80% confluence. The optimum seeding 
densities (70-80% confluency) for both cells were observed 
and chosen for the LIUS experiment. 
ULTRASOUND TREATMENT
A Sonopuls 491 (Enraf-Nonius, Rotterdam, Amsterdam) 
ultrasound source was used in this study. Its transducer 
was immersed in a water bath filled with deionized water 
maintained at 37°C and the water was changed every day. 
The 6-well plate containing cells (MCF-7 cells were plated 
at 1×106 cells/well while CHO at 4×105 cells/well) was 
placed on top of the transducer while the control group 
was maintained in the same conditions without being 
exposed to the ultrasound. The ultrasound stimulation was 
performed 10 min every day for 3 days at the frequency of 
1 MHz and an intensity of 0.1 W/cm2. Treated and control 
samples were analyzed after 1, 2 and 3 days to determine 
the cells proliferation, percentage of live/dead cells and 
the induction of apoptosis; at each time period results for 
each analysis were obtained from 3 different samples. 
CYTOTOXICITY ASSAY
MTT assay was performed on 3 days interval for both MCF 
7 and CHO cells. MTT solution (5 mg/mL) was prepared 
in PBS buffer. The media was discarded and the freshly 
prepared 250 μL of MTT solution and 1750 μL of media 
were added to each well containing the cells and left for 
4 h in the CO2 incubator. After that, the precipitate was 
dissolved with 4.5 mL 1NHCl/Isopropanol and left for 
15 min for the formazan to be dissolved. The absorbance 
was read at a wavelength of 570 nm using a microplate 
reader (Epoch-Micro, Bio-Tek Instruments, USA ) (Uludag 
& Sefton 1990). The samples were done in triplicate for 
both the control and the treated cells for 3 days interval.
LIVE-DEAD ASSAY
Live and Dead assay was done by using a method 
previously described (Bohari et al. 2011) with slight 
modification. The control and treated groups were 
visualized using the inverted microscope (Nikkon Eclipse 
TS 100, Nikon Instrument Inc. USA) every day for 3 days 
interval after the ultrasound exposure. After 3 days, the 
media in each well was discarded and 1 mL of PBS was 
added to wash the cells. 300 μL of trypsin was added into 
the wells after the PBS solution was discarded. The cells 
were incubated for 5 min in the CO2 incubator to allow 
cells detachment. Then, 700 μL media was added into 
each well and the cell suspension was transferred into 
1.5 mL microcentrifuge tube. Propidium Iodide (25 μL, 
150 μM) and Calcein AM (2 μL, 100 μM) were added 
into each microcentrifuge tube and re-suspended. The 
cell suspensions were incubated for 15-20 min at room 
temperature in the dark for the staining purposes. Then, 
40 μL of the stained cell suspension were transferred 
onto glass slides and covered with coverslip. The images 
of the stained cells under the fluorescence microscope 
(Nikon Eclipse-Ti-S Inverted Microscope System, New 




Total RNA was isolated from the treated cancer cells and 
the control cells by using the RNA isolation kit (GeneJET 
RNA purification kit. Thermo Fischer Scientific, USA) 
according to the manufacturer’s instructions. cDNA was 
synthesized using Maxima Reverse Transcriptase Kit 
(Thermo Fischer Scientific, USA. cat#EP0742). The 
standard curves were obtained using serial dilutions 
of the cDNA and beta-actin (House Keeping Gene). 
Quantitative Real-Time-PCR assay was performed based 
on the SYBR Green (Maxima SYBR Green qPCR Master 
Mix, Thermo Fisher Scientific, USA cat# K0252). Gene-
specific primers were obtained from Integrated DNA 
Technologies (Iowa, USA). The p53 forward primer: 5’- 
AGCATCTTATCCGAGTGGAAGGAA-3’ and Reverse 
sequence: 5’- TTATGGCGGGAGGTAGACTGACC-3’, for 
β-actin, Forward: 5’- GATGGTGGGAATGGGTCAGA-3’, 
Reverse: 5’- GGAGAGCATAGCCCTCGTAGAT-3’. The 
gene expression values obtained were normalized using 
a housekeeping gene copy numbers of mRNA which 
were calculated from the serially diluted standard curves 
generated from the cDNA template. 
STATISTICAL ANALYSIS
The Shapiro-Wilk test (Pallant 2007) for the normality test 
was done for all of the data. The data were analysed using 
Mann-Whitney test for Non-normal data and Independent 
t-test for normal data (Pallant 2007). The differences were 
considered significant if p<0.05. 
RESULTS
EFFECT OF CONTINUOUS LOW INTENSITY ULTRASOUND 
TREATMENT ON CELLS PROLIFERATION
The exposure of therapeutic ultrasound on MCF-7 cells 
was investigated in the duration of three day intervals. As 
shown in Figure 1(a), the reading patterns for the control 
and treatment groups increased from Day 1 up to Day 
3. However, the number of cancer cells in the treatment 
group was less compared to the control group. This showed 
that the mechanical vibration generated by the ultrasound 
exposure inhibited the proliferation of the cancer cells and 
caused a decrease in the number of cells throughout the 
course of the study (Watanabe et al. 2002). However, for 
CHO cells as shown in Figure 1(b), ultrasound exposure 
to the treatment group had little or no deleterious effect 
to the cells; as seen when compared to the control group.
From the quantitative analysis shown in Figure 1(c), the 
percentage inhibition of MCF-7 cells increased from Day 
1 to Day 3. Almost more than half of the total inhibition 
was observed in MCF-7 cells while CHO cells showed less 
than 1% of growth inhibition. A possible explanation is 
that malignant cells such as the breast cancer cells were 
highly susceptible to growth retardation by ultrasound (Li 
et al. 2012; Wang et al. 2013).
 Previous studies have generalized the effect of 
ultrasound on normal cells; in vivo studies by Nonaka 
et al. (2009) showed that ultrasound selectively killed 
tumor without damaging the intervening or surrounding 
normal brain tissues in rats. The activation of the ultrasonic 
exposure significantly enhanced the antitumor effect, 
without the risk of damaging normal intervening brain 
tissues (Nonaka et al. 2009). Naturally occurring cancer 
cells possessed higher entropy production rates. The ability 
of entropy to flow to the normal cell will transmit related 
information from the cancerous cell to the normal cells 
causing force malignancy. While ultrasound treatment 
reversed this direction, it will induce a reverse of the 
information from the healthy cell to the cancerous cell as 
cancer cell possessed higher absorption capability (Luo et 
al. 2013; Park et al. 2013).
 As stated in a previous study, the therapeutic dosage of 
the ultrasound may not be in adequate amount to cease the 
growth of MCF-7 cells (Wang et al. 2013; Yu et al. 2004). 
In fact, bio-effects of ultrasound alone on cancer cells is 
tissue-dependent, suggesting that applying an identical 
ultrasound parameters for all types of tissue were not an 
effective approach. In contrast, employing an optimized 
FIGURE 1. Cytotoxicity study on a) MCF-7 and b) CHO cells in three days interval after treatment with continuous therapeutic 
ultrasound. Each result indicated the mean of the three observations and the error bars represent the standard deviation. 
Results which are significantly different (p<0.05) were marked with an asterisk*
(a) (b)
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ultrasound parameters can increase its bio-effects alone 
and or with the combination of cancer drugs (Wang et al. 
2013; Yu et al. 2004). 
LIVE/DEAD STAINING ON THE MCF-7 AND CHINESE 
HAMSTER OVARY (CHO) CELLS AFTER THE CONTINUOUS 
ULTRASOUND TREATMENT
During the 72 h (3 days) of ultrasound treatment, it can be 
seen that the treated MCF-7 cells showed the highest number 
of dead cells through the detection of red fluorescence 
cells when stained with Propidium Iodide (PI) instead 
of the green cells stained with Calcein AM (CAM) when 
compared to the control (Figure 2(a)). On the other hand, 
for the CHO cells, no significant differences were detected 
between the treated and non-treated cells (Figure 2(b)). 
The increasing number of MCF-7 cells taking up the PI stain 
could happen due to the presence of breakage or damaged 
cells in the population of the treated cells. Therefore, 
the number of dead cells that can be detected within the 
population increased. Meanwhile, only a few numbers of 
red fluorescent CHO cells were observed via the inverted 
fluorescence microscope. This shows that the therapeutic 
ultrasound did not affect the proliferation of normal cells 
due to the low rate of temperature absorption and heat 
transfer to the cancerous cells (Luo et al. 2006; Park et 
al. 2013).
 Moreover, the control group of MCF-7 (cancerous 
cells) and CHO (non-cancerous cells) cells, also represents 
dead cells but it was very little when compared to the 
treated groups. This might probably happen due to the 
trypsinization and incubation process that may somehow 
induce damages to the cells during the preparation stage 
(Tsao et al. 1999).
 The fluorescent images were captured and the viability 
percentage of MCF-7 and CHO cells were calculated by using 
the formula below (Bohari et al. 2011):
Viability (%) = (Total cells – Dead cells)/Total cells ×100%.
 
 The viability of MCF-7 after the exposure with the 
therapeutic ultrasound for 3 days treatment shows a 
decreased from 93%, 90% and until 83%, respectively 
(Figure 2(b)). However, for the treated CHO cells, the 
decrement was only 2% for the whole 72 h (Figure 2(b)). 
Moreover, statistical study did not show any significant 
different between treated and control CHO cells group. 
Therefore, the results clearly demonstrated the effect of 
the therapeutic dosage of ultrasound treatment on the 
growth of MCF-7 in contrary to a very minimal effect of 
the treatment on CHO cells. 
 Even though there was decrease in viability of the 
MCF-7 cells, the data showed a significance p<0.01 for 
the 24 h treatment of the treated MCF-7 compared to 
control. Whereas the treated MCF-7 cells did not show any 
significant result after 48 and 72 h. 
 The results obtained showed that the MCF-7 percentage 
of viability has reduced compared to non- cancerous cell 
lines CHO which has an approximately constant percentage 
of viability. As proposed earlier, MCF-7 cells was more 
susceptible towards retardation or inhibition of growth 
when exposed to ultrasound treatment compared to the 
normal cells (Jia et al. 2015; Lejbkowicz & Salzberg 
1997). Thus, with this specific intensity, the therapeutic 
ultrasound treatment has the possibility to disrupt the 
MCF-7 membrane (Furusawa et al. 2012; Symmans et al. 
2000); subsequently induce biological damage caused by 
the cavitation process due to the applied heat (Miller et al. 
2012). As a result from the mechanical stress of therapeutic 
ultrasound, cell to cell attachment was disrupted which led 
to apoptosis and increased the cell membrane permeability 
towards PI staining (Darzynkiewicz et al. 1992; Rieger et 
al. 2011; Vermes et al. 2000, 1995). 
APOPTOTIC PROTEIN DETECTION
Ultrasound has been shown to induce apoptosis in many 
experimental systems. Thus, in the present study, we 
attempted to detect p53 which is the key apoptosis element 
at mRNA level in order to evaluate whether ultrasound could 
induce apoptosis in MCF-7 with less harm to the control 
CHO cells. The occurrence of apoptosis was estimated by 
real-time PCR analysis of p53-mRNA. High expression level 
of p53-mRNA was detected in the first 24 h after ultrasound 
FIGURE 1(c). Percentage inhibition for both cells (CHO and MCF 7) for the period of three days. 
The results are shown based on the specific calculation involving the control and 
treatment days. Error bars represent the standard deviation
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treatment (Figure 3). Furthermore, after 72 h of incubation, 
MCF-7 cells showed gradual decrease of p53-mRNA while 
CHO cells showed no significant difference in the level 
of mRNA during the 72 h. For the CHO cells, less amount 
of mRNA was detected after 24 h of treatment. This data 
suggested that ultrasound could induce apoptosis or cell 
death of the MCF-7 cells, but had no effects on normal and/
or healthy cells.
DISCUSSION
Apoptosis is characterized by a number of well understood 
features including the activation of related signalling 
pathways and their downstream proteins such as Caspases, 
p53 and Rb. It is well understood that a wide range of 
intrinsic and extrinsic factors, signal-stimulus pathways 
and mechanical forces can activate apoptosis and its 
complex dynamic network (Li et al. 2012). Several 
studies have shown that ultrasound treatment, albeit a new 
approach, can potentially activate apoptosis (Dubinsky 
et al. 2008; Li et al. 2012; Wang et al. 2013) and/or 
increase the sensitivity of cancer cells for the uptake of 
chemotherapy drugs (Chumakova et al. 2006; Ninomiya 
et al. 2014).
 These results demonstrated that ultrasound treatment 
at a specific dosage has the ability to inhibit proliferation 
of MCF7 cells. As shown in Figure 1(c), proliferation of 
MCF-7 cells was inhibited the most after 72 h of exposure. 
FIGURE 2(a). Live and dead assay staining showed viable (green) and dead (red) cells 
for MCF-7 and CHO cell lines; 24 h, 48 h and 72 h
FIGURE 2(b). Percentage of viability of the MCF-7 and CHO viable cells, measured from the specimens 
stained with Propidium Iodide and Calcein AM. Each results is the mean value of the triplicate 
observations and the error bars represented the standard deviation, ** p< 0.01
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The results obtained from the MTT assay which showed 
that exposure to the therapeutic dosage of ultrasound only 
inhibited proliferation of cancer cell line (MCF-7) without 
any significant inhibition to the normal cell line (CHO). 
 It is understood that ultrasonic hyperthermia may lead 
to its therapeutic effects by arresting the cancer cells in the 
S phase of the cell cycle and may have superior effects on 
hypoxic, acidic and malnourished tumor cells (Paliwal & 
Mitragotri 2008). Previous study has generalized the effect 
of ultrasound on normal cells; in vivo studies by Nonaka 
et al. (2009) stated that ultrasound selectively killed tumor 
without damaging or intervening with the surrounding 
normal brain tissues in rats. Studies conducted by Luo et 
al. (2006) and Wang et al. (2013) also demonstrated that 
an appropriate and effective dosage may eliminate all of 
the cancer cells.
 The microscopic analysis of the Live/Dead assay 
indicate the inhibitory effect of ultrasound on a wide range 
of cancerous cells compared to normal cells throughout 
the course of study (Figure 2(a) and 2(b)). Furthermore, 
the wavelength applied on MCF-7 cells did not show any 
significant effect after 24 h of treatment. This may have 
occurred due to the activation of anti-apoptotic signalling 
pathways on MCF-7 cells against the therapeutic ultrasound 
treatment.
 In addition to these results and in relation to previous 
studies (Li et al. 2012), ultrasound treatment enhanced 
the level of p53-mRNA expression which can be detected 
by means of qPCR, indicating the induction of apoptosis 
and inhibition of cell growth (Figure 3). The large body of 
evidences indicated that cancer cell lines with wild type 
p53 are more sensitive when treated with apoptosis-based 
drugs and/or with the ultrasound treatment (Hupp et al. 
2000). One possible reason is that, cancer cells with the 
mutated p53 show more stability of p53 protein at high 
level than the wild-type (Hui et al. 2006). Inversely, we 
demonstrated that the level of p53-mRNA decreased after 
72 h while the inhibition of cancer cells increased (Figure 
1(c)). This may have occurred as the ultrasound treatment 
activates another apoptosis mechanism. A recent study 
showed that ultrasound can induce apoptosis through 
the activation of Caspase-3 and Caspase-9 as the main 
component of apoptosis (Li et al. 2012).
 Additionally, some signalling pathways responding 
to ultrasound-induced apoptosis were also suggested; for 
example, the mitochondrial pathway Bcl-2 family together 
with p53, and the oxidative stress signalling pathway 
accompanied with Heme-Oxygenase I and Heat Shock 
Proteins (Feng et al. 2010). However, the exact mechanism 
of apoptosis via ultrasound is still unclear. Our study 
provided a new approach in eliminating malignant breast 
cancer cell by means of ultrasound alone. Further studies 
are required to understand the exact apoptosis mechanism 
through a continuous low intensity ultrasound.
CONCLUSION
In conclusion, findings from the study suggested that low 
intensity ultrasound at a specific dose has a significant 
effect in inducing apoptosis in breast cancer cells with 
minimal harm to normal cells.
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